Last updated: February 15, 2026
Overview of NDC 61314-0224
NDC 61314-0224 is identified as a specific pharmaceutical product on the National Drug Code directory. Its indications, formulation, and regulatory status are critical for market positioning. Based on available data, the drug appears to be used in the treatment of [specify condition if known], with formulation details involving [e.g., oral tablet, injection].
The drug has received FDA approval on [date], with a patent expiry scheduled for [date], influencing potential market exclusivity and competition.
Market Landscape Analysis
Current Market Size
The global drug market for [therapeutic class] was valued at approximately $XX billion in 2022, with the US accounting for nearly XX%. The segment relevant to NDC 61314-0224 had an estimated size of $XX million in 2022, driven by prevalence of [target condition], treatments in development, and off-label use.
Competitive Environment
Key competitors include drugs [Name 1], [Name 2], and [Name 3]. These offer similar mechanisms of action or targeted indications, with respective market shares of approximately XX%, XX%, and XX%. The competitive landscape is characterized by:
- Entry barriers such as patent protection.
- Pricing strategies ranging from $XX to $XX per unit.
- Different administration routes with implications for patient compliance and reimbursement.
Regulatory and Reimbursement Factors
Reimbursement policies favor drugs with demonstrated cost-effectiveness, especially in the US Medicare and Medicaid programs. CMS coverage decisions significantly influence market penetration. Orphan drug status, if granted, can provide extension of exclusivity and market advantages.
Pricing Trends and Historical Data
Existing products in this class typically retail between $XX and $XX per dose/unit. Recent launches have seen initial pricing at the higher end, with subsequent reductions due to biosimilar or generic competition, which could occur within X years post-approval.
Price Projections
Assumptions
- The drug gains full regulatory approval and patent exclusivity for the projected period.
- No significant changes in reimbursement policy.
- Competitive landscape remains stable over the forecast horizon.
- Launch occurs in Q1 2024.
Short-Term Pricing (Year 1-2)
Initial pricing is expected to be set at $XX per dose, based on comparator analysis and manufacturer positioning. This price aligns with similar therapeutic agents and accounts for R&D and commercialization costs.
Mid-Term Pricing (Years 3-5)
As market penetration stabilizes, prices are forecasted to decline by approximately XX% due to entry of biosimilars or generics, reaching around $XX per dose. Volume growth is projected at X% annually, driven by increased adoption and expanded indications.
Long-Term Pricing (Years 6+)
Market saturation and increased competition likely drive prices down to $XX per dose, comparable with existing generics. Alternatively, if the drug secures new indications or formulations, pricing could stabilize or increase marginally.
Revenue Projections
Based on volume assumptions and price trajectories:
| Year |
Estimated Units Sold |
Average Price |
Revenue Projection |
| 2024 |
X million |
$XX |
$XX million |
| 2025 |
X.2 million |
$XX |
$XX million |
| 2026 |
X.5 million |
$XX |
$XX million |
Market share assumptions suggest revenue can reach approximately $XX million in Year 3, with potential growth contingent upon adoption rates and reimbursement conditions.
Risks and Opportunities
- Risks: Delay in regulatory approval, pricing pressures, patent litigation, faster-than-expected biosimilar entry.
- Opportunities: Expansion into new markets, development of combination therapies, orphan drug designation leading to extended market exclusivity.
Key Takeaways
- NDC 61314-0224 operates within a competitive market with established players.
- Initial pricing anticipated around $XX per dose, declining over time due to competition.
- Revenue hinges on uptake, reimbursement policies, and patent protection.
- Strategic market entry timing and indication expansion are crucial for maximizing returns.
FAQs
1. What factors influence the pricing of NDC 61314-0224?
Pricing is influenced by manufacturing costs, competitive landscape, regulatory status, reimbursement policies, and market demand.
2. When is biosimilar competition expected?
Biosimilar entries generally occur 8–12 years after patent expiry, which for this drug is projected around [specific year].
3. How does orphan drug designation affect market potential?
It extends market exclusivity, reduces competition, and can justify higher prices during this period.
4. What are the primary market risks?
Regulatory delays, patent litigations, market entry of cheaper alternatives, and reimbursement hurdles.
5. How does the current market size influence future revenue projections?
A larger existing market allows for greater sales volume, boosting long-term revenue potential if market access is secured.
References
[1] FDA Drug Approvals Database, 2022.
[2] IQVIA, Market Analytics, 2022.
[3] Centers for Medicare & Medicaid Services, Reimbursement Policies, 2023.
